Top

Published in:

01-10-2013 | Letter to the Editor

Comment on: “Management of Alcohol Dependence in Patients With Liver Disease”

Authors: Benjamin Rolland, Sylvie Deheul, Alexandre Louvet, Olivier Cottencin, Régis Bordet

Published in: CNS Drugs | Issue 10/2013

Excerpt

Addolorato et al. [1] recently published a welcome review article in CNS Drugs, entitled “Management of alcohol dependence in patients with liver disease”. Alcoholic liver disease (ALD) is too often forgotten within the numerous review articles that are regularly published on alcohol-dependence medications, whereas cirrhosis is one of the most dramatic consequences of alcohol dependence and can deeply affect the safe use of numerous medications. …

Addolorato G, Mirijello A, Leggio L, Ferrulli A, Landolfi R. Management of alcohol dependence in patients with liver disease. CNS Drugs. 2013;27(4):287–99.PubMedCrossRef

Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet. 2007;370(9603):1915–22.PubMedCrossRef

Sergeeva OA. GABAergic transmission in hepatic encephalopathy. Arch Biochem Biophys. 2013; doi:10.1016/j.abb.2013.04.005.

Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, et al. Dose–response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol. 2011;46(3):312–7.PubMedCrossRef

Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 2005;40(2):147–50.PubMedCrossRef

Bucknam W. Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol. 2007;42(2):158–60.PubMedCrossRef

de Beaurepaire R. Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patients. Front Addict Disord Behav Dyscontrol. 2012;3:103.

Rigal L, Alexandre-Dubroeucq C, de Beaurepaire R, Le Jeunne C, Jaury P. Abstinence and ‘low-risk’ consumption 1 year after the initiation of high-dose baclofen: a retrospective study among ‘high-risk’ drinkers. Alcohol Alcohol. 2012;47(4):439–42.PubMedCrossRef

Pastor A, Jones DML, Currie J. High-dose baclofen for treatment-resistant alcohol dependence. J Clin Psychopharmacol. 2012;32(2):266–8.PubMedCrossRef

10.

Rolland B, Bordet R, Cottencin O. Alcohol-dependence: the current French craze for baclofen. Addiction. 2012;107(4):848–9.PubMedCrossRef

Title: Comment on: “Management of Alcohol Dependence in Patients With Liver Disease”
Authors: Benjamin Rolland
Sylvie Deheul
Alexandre Louvet
Olivier Cottencin
Régis Bordet
Publication date: 01-10-2013
Publisher: Springer International Publishing
Published in: CNS Drugs / Issue 10/2013
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI: https://doi.org/10.1007/s40263-013-0109-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comment on: “Management of Alcohol Dependence in Patients With Liver Disease”

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2013

Authors’ Reply to Rolland et al.: “Management of Alcohol Dependence in Patients with Liver Disease”

Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders

Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression

Modelling the Risk of Visual Field Loss Arising from Long-Term Exposure to the Antiepileptic Drug Vigabatrin: A Cross-Sectional Approach

Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder

Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy